What are the potential side effects of a Positron Emission Tomography (PET) scan, particularly in patients with a history of cancer or other medical conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Side Effects of PET Scans

Radiation Exposure: The Primary Risk

PET scans expose patients to ionizing radiation with a total effective dose of approximately 10 mSv per procedure, consisting of 6-7 mSv from the radiopharmaceutical (typically 18F-FDG) and 2-4 mSv from the low-dose CT component. 1 If a full diagnostic CT is performed rather than a low-dose CT, the total radiation exposure can be considerably higher. 1

Biological Effects of Radiation

  • DNA damage and chromosomal aberrations have been documented in lymphocytes following 18F-FDG PET/CT scanning, with chromosome aberration assays showing statistically significant increases post-scanning compared to pre-scanning levels. 2
  • The entrance surface dose (ESD) varies by body region, ranging from approximately 32 mGy for head and shoulder regions to 43 mGy for pelvic regions. 2
  • Effective doses from the CT component alone can range from 16.40 to 72.18 mSv depending on the protocol used, with dose length products varying from 1093 to 4812 mGy*cm. 2
  • Inter-individual variation in induced DNA damage occurs among patients, suggesting that some individuals may be more susceptible to radiation effects than others. 2

Special Population Considerations

Pregnancy and Breastfeeding

  • PET/CT procedures should be avoided or postponed in pregnant patients unless the examination is vital for the patient's care. 1
  • Interruption of breastfeeding is not necessary after a PET/CT procedure in nursing mothers. 1
  • Close contact between the patient and small children should be avoided for several hours after radiopharmaceutical administration due to residual radiation emission from the patient. 1

Pediatric Patients

  • Pediatric patients face unique radiation safety concerns due to their increased radiosensitivity and longer life expectancy for potential late effects to manifest. 3
  • The combination of two radiation-exposing procedures (PET and CT) creates heightened concern in this population. 3

Contrast Agent Considerations

  • When performing PET/CT with intravenous contrast agents, standard CT contrast-related adverse effects may occur, including allergic reactions and nephrotoxicity. 4

Radiation Protection for Personnel and Public

  • Healthcare personnel face radiation exposure primarily from handling radiopharmaceuticals (syringe withdrawal, injection, waste handling) and close contact with patients. 1
  • The radiation dose to personnel can be limited by applying the inverse-square law—maintaining maximum practical distance from the radiation source substantially decreases absorbed dose. 1
  • The energetic nature of positron-emitting radiation requires special radiation protection routines beyond those used for standard diagnostic imaging. 1

Common Pitfalls to Avoid

  • Performing a CT scan prior to PET/CT without clinical justification results in unnecessary additional radiation exposure that should be avoided. 1
  • Failure to maintain adequate distance from patients after radiopharmaceutical injection increases unnecessary radiation exposure to family members and caregivers. 1
  • Not considering cumulative radiation exposure from multiple imaging studies can lead to underestimation of total patient radiation burden. 2

Long-Term Risk Considerations

  • The biologically significant radiation dose received during 18F-PET/CT scanning may carry long-term risks, and precautions should be taken to reduce exposure when possible. 2
  • Low-dose radiation exposure can induce an adaptive response in cells, potentially requiring higher therapeutic doses for efficacy while simultaneously increasing toxicity to normal cells. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.